Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that, through its Calando Pharmaceuticals subsidiary, it has completed enrollment of a phase 1b clinical ...

LOWELL — The Cambodian American Literary Arts Association is a new nonprofit organization in Lowell that educates and empowers the Cambodian and multicultural communities through the literary arts.

Calando recently proved systemic siRNA delivery and RNAi-mediated mRNA knockdown. Arrowhead Research has increased its ownership of majority-owned subsidiary Calando Pharmaceuticals through the ...

Calando Pharmaceuticals has announced that pre-clinical development of a second siRNA oncology therapeutic, CALAA-02, is underway. The intracellular target for CALAA-02 is HIF-2alpha, or Hypoxia ...

Calando Pharmaceuticals, Inc. has the issuance of U.S. Patent No. 7,427,605, entitled, “Inhibitors of ribonucleotide reductase subunit 2 and uses thereof.” The patent contains claims directed to ...

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with development programs in oncology, obesity and regenerative medicine, today announced that ...